- Home
- EYPT vs SPB Comparison
EYPT vs SPB Comparison
Compare EYPT & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EYPT | SPB |
|---|---|---|
| Founded | 1987 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
| Sector | Industrials | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.9B |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | EYPT | SPB |
|---|---|---|
| Price | $14.70 | $79.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $31.80 | ★ $82.40 |
| AVG Volume (30 Days) | ★ 795.3K | 266.7K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.37% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.21 |
| Revenue | $7,539,000.00 | ★ $3,802,100,000.00 |
| Revenue This Year | N/A | $1.99 |
| Revenue Next Year | $3,115.57 | $1.85 |
| P/E Ratio | ★ N/A | $65.42 |
| Revenue Growth | N/A | ★ 20.86 |
| 52 Week Low | $5.44 | $49.99 |
| 52 Week High | $19.11 | $80.50 |
Technical Indicators
Market Signals| Indicator | EYPT | SPB |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 60.49 |
| Support Level | $14.50 | $73.37 |
| Resistance Level | $18.99 | $80.46 |
| Average True Range (ATR) | 0.66 | 2.16 |
| MACD | 0.25 | 0.43 |
| Stochastic Oscillator | 92.13 | 86.16 |
Price Performance
Historical ComparisonAbout EYPT EyePoint Pharmaceuticals Inc.
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
About SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.